Janssen Oncology Newsroom
Welcome to the Janssen Oncology AUA, WCLC and ESMO Virtual Newsroom
At the Janssen Pharmaceutical Companies of Johnson & Johnson, our commitment to patients, caregivers and clinicians goes beyond medicine. Our goals are big. We aim to eliminate cancer. Through our tireless work to advance scientific innovation, address unmet medical needs and improve outcomes for patients – we believe it’s possible.
At the 2021 American Urological Association (AUA), World Conference on Lung Cancer (WCLC) and European Society for Medical Oncology (ESMO) annual meetings, we will feature multiple presentations in prostate cancer, lung cancer and bladder cancer, which highlight our efforts to reimagine treatments, to help people live longer and better. We are also dedicated to collaborating with the entire care community, including oncologists and urologists, to provide support beyond our medicines.
We look forward to contributing to important scientific exchange that is foundational to the advancement of medicine and patient care. Thank you for visiting Janssen's 2021 Virtual Newsroom for AUA, WCLC and ESMO 2021 to learn more about our latest research.
Peter Lebowitz, M.D., Ph.D.
Global Therapeutic Area Head, Oncology
Janssen Research & Development, LLC.
President, Janssen Oncology
Janssen Biotech, Inc.